antidepressant peer group review

This is a peer review of a PowerPoint presentation. Below are the scenarios they were presented with. Please review and state why u agree with their finding with supportive references
I need 2 professional references. I will place the books for the class below u can use them as references. please no mayo clinic references etc..

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. (5th Ed.).
American Psychiatric Association.
American Psychological Association (2020). Publication manual of the American Psychological Association (7th ed.).
American Psychological Association.
Stahl, S. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical application. 5th Ed.
Cambridge University Press.
Stahl, S. (2021). The prescriber’s guide: Stahl’s essential psychopharmacology. 7th Ed. Cambridge University Press.
Stern, et al., (2018). Handbook of general hospital psychiatry (7th Ed.). Saunders.
Wheeler, K. (2014). Psychotherapy for the advanced practice psychiatric nurse. Springer Publishing Company, LLC.

Depression Case Studies

Patti is a 50-year-old perimenopausal patient with a history of depression. Her depressed mood seems to be responding to her current treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (40 mg/day); however, she is troubled by hot flashes and night sweats, and she reports some residual depressed mood.
Which treatment strategy is likely to optimize this patient’s chance for remission?
How does the recommendation that you just made work?
What is the likelihood of achieving remission after the second antidepressant?
John is 68 year old who recently suffered a heart attack. He is in cardiac rehab and has become very depressed.
What medication will you consider and why? Is there any antidepressant to avoid?
You have started John on an antidepressant, and now he is having sexual side effects.

What would you recommend?

Ray, a 35-year-old male, has only partially responded to his second monotherapy with a first-line antidepressant at its maximum dose.

What has the best evidence of efficacy for augmenting an antidepressant in patients with an inadequate response?

Donna is a 30-year-old woman who comes to you after being treated with Effexor 75 mg for depression by her PCP for the last 12 months. She reported that her depressive symptoms have subsided, but she is very anxious.

What would you do? Explain.

Jessica just had a baby and cannot remember the name of her antidepressant medication that she was on throughout her pregnancy? She reported that her baby had some tremors and seemed sluggish, and a little out of it when the baby was in the nursery. They placed the baby in the NICU for some rapid breathing and respiratory distress.
What was wrong?
Jessica wants to stay on her antidepressant and continue to breastfeed. What do you think about this? Explain.